Transcripts Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 19:20:00 18/09/2026 +04			5-day change	1st Jan Change
40.50 ^DKK	+2.66%		-7.53%	+11.88%

09-11	Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome	MT
09-11	Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome	FW

08-19	H. Lundbeck A/S, Q2 2026 Earnings Call, Aug 19, 2026
06-05	H. Lundbeck A/S - Special Call
05-13	H. Lundbeck A/S, Q1 2026 Earnings Call, May 13, 2026
03-18	H. Lundbeck A/S - Shareholder/Analyst Call
02-04	H. Lundbeck A/S, Q4 2025 Earnings Call, Feb 04, 2026
11-12	H. Lundbeck A/S, Q3 2025 Earnings Call, Nov 12, 2025
14/08/25	H. Lundbeck A/S, H1 2025 Earnings Call, Aug 14, 2025
14/05/25	H. Lundbeck A/S, Q1 2025 Earnings Call, May 14, 2025
26/03/25	H. Lundbeck A/S - Shareholder/Analyst Call
05/02/25	H. Lundbeck A/S, 2024 Earnings Call, Feb 05, 2025
14/01/25	H. Lundbeck A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 04:30 PM
13/11/24	H. Lundbeck A/S, Q3 2024 Earnings Call, Nov 13, 2024
23/10/24	H. Lundbeck A/S - Analyst/Investor Day
14/10/24	H. Lundbeck A/S, Longboard Pharmaceuticals, Inc. - M&A Call
21/08/24	H. Lundbeck A/S, H1 2024 Earnings Call, Aug 21, 2024
15/05/24	H. Lundbeck A/S, Q1 2024 Earnings Call, May 15, 2024
20/03/24	H. Lundbeck A/S - Shareholder/Analyst Call
07/02/24	H. Lundbeck A/S, 2023 Earnings Call, Feb 07, 2024
31/01/24	H. Lundbeck A/S - Special Call
08/01/24	H. Lundbeck A/S Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10:30 AM
30/11/23	H. Lundbeck A/S - Special Call